您的位置: 首页 > 2016年11月 第47卷 第6期 > 文字全文
2023年7月 第38卷 第7期11
目录

血清IL-33水平与老年COPD患者病程分期的相关性研究

Relevant research between serum IL-33 level and the stage of disease in elderly patients with chronic obstructive pulmonary disease

来源期刊: 广州医药 | 26-28 发布时间:2021-12-02 收稿时间:2025/11/13 16:52:23 阅读量:17
作者:
关键词:
老年人慢性阻塞性肺病IL-33发病机制
ElderlyChronic obstructive pulmonary diseaseIL-33Pathogenesis
DOI:
10.3969/j.issn.1000-8535.2016.06.008
收稿时间:
2016-08-29 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 研究老年慢性阻塞性肺病(COPD)患者血清IL-33水平与其病程分期的相关性。方法 选择60例老年COPD患者作为观察组,按病程分期分为稳定期组和急性加重组,另选择15例非COPD老年患者作为对照组;分别检测血清IL-33水平。结果 各组组间比较结果显示,AECOPD组和COPD稳定期组的血清IL-33水平均高于对照组(P<0.05),其中,AECOPD组的比COPD稳定期组的更高(P<0.05)。结论 血清IL-33水平在老年COPD患者中增高,急性加重期更明显,提示IL-33在老年人COPD发生、发展中可能起重要作用。
Objective To have relevant research between serum IL-33 level and the stage of disease in elderly patients with chronic obstructive pulmonary disease(COPD). Methods 60 elderly patients with COPD were selected as the observation group, who were divided into stable COPD group and AECOPD group. The other 15 patients with non-COPD were selected as the control group. The serum IL-33 levels were detected respectively. Results The comparison results between the groups showed that the serum IL-33 levels in the AECOPD group and the stable COPD group were higher than those in the control group(P<0.05), which was higher in the AECOPD group than in the COPD group(P<0.05). Conclusion Serum IL-33 levels were increased in elderly patients with COPD, the increase in acute exacerbation was more obvious, suggesting that IL-33 may play an important role in the occurrence and development of COPD in the elderly.
1、 QIU C, LI Y, LI M, et al. Anti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in mice[J]. Immunol, 2013,138(1): 76-82. QIU C, LI Y, LI M, et al. Anti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in mice[J]. Immunol, 2013,138(1): 76-82.
2、 WU H, YANG S, WU X, et al. Interleukin-33/ST2 signaling promotes production of interleukin-6 and interleukin-8 in systemic inflammation in cigarette smoke-induced chronic obstructive pulmonary disease mice[J]. Biochem Bioph Res Co, 2014,450(1):110-116. WU H, YANG S, WU X, et al. Interleukin-33/ST2 signaling promotes production of interleukin-6 and interleukin-8 in systemic inflammation in cigarette smoke-induced chronic obstructive pulmonary disease mice[J]. Biochem Bioph Res Co, 2014,450(1):110-116.
3、 XIA J, ZHAO J, SHANG J, et al. Increased IL-33 expression in chronic obstructive pulmonary disease[J]. Am J Physiol Lung Cell Mol Physiol, 2015,308(7): 619-627. XIA J, ZHAO J, SHANG J, et al. Increased IL-33 expression in chronic obstructive pulmonary disease[J]. Am J Physiol Lung Cell Mol Physiol, 2015,308(7): 619-627.
4、 LIEW FY. Cigarette smoke resets the alarmin IL-33 in COPD[J]. Immunity, 2015,42(3):401-403. LIEW FY. Cigarette smoke resets the alarmin IL-33 in COPD[J]. Immunity, 2015,42(3):401-403.
5、 CARRIERE V, ROUSSEL L, ORTEGA N, et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo[J]. Proc Nati Acad Sci USA, 2007,104(1):282-287. CARRIERE V, ROUSSEL L, ORTEGA N, et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo[J]. Proc Nati Acad Sci USA, 2007,104(1):282-287.
6、 SCHMITZ J, OWYANG A, OLDHAM E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines[J]. Immunity, 2005, 23(5): 479-490. SCHMITZ J, OWYANG A, OLDHAM E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines[J]. Immunity, 2005, 23(5): 479-490.
7、 LIANG F, HUANG N, WANG B, et al. Shear stress induces interleukin-8 mRNA expression and transcriptional activation in human vascular endothelial cells[J]. Chin Med J, 2002, 115(12): 1838-1842. LIANG F, HUANG N, WANG B, et al. Shear stress induces interleukin-8 mRNA expression and transcriptional activation in human vascular endothelial cells[J]. Chin Med J, 2002, 115(12): 1838-1842.
8、 SNOW V, LASCHER S, MOTTUR-PILSON C, et al. The evidence base for management of acute exacerbations of COPD: clinical practice guideline, part[J]. Chest, 2001, 119(4): 1185-1189. SNOW V, LASCHER S, MOTTUR-PILSON C, et al. The evidence base for management of acute exacerbations of COPD: clinical practice guideline, part[J]. Chest, 2001, 119(4): 1185-1189.
9、 EAGAN TM, UELAND T, WAGNER PD,et al. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study[J]. Eur Respir J, 2009, 35(3): 540-548. EAGAN TM, UELAND T, WAGNER PD,et al. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study[J]. Eur Respir J, 2009, 35(3): 540-548.
10、 BARNES PJ. Immunology of asthma and chronic obstructive pulmonary disease[J]. Nat Rev Immunol, 2008,8(3): 183-192. BARNES PJ. Immunology of asthma and chronic obstructive pulmonary disease[J]. Nat Rev Immunol, 2008,8(3): 183-192.
11、 中华医学会呼吸病学分会COPD学组. 慢性阻塞性肺疾病诊治指南(2013年修订版)[J]. 中华结核和呼吸杂志,2013,36(4):1-9. 中华医学会呼吸病学分会COPD学组. 慢性阻塞性肺疾病诊治指南(2013年修订版)[J]. 中华结核和呼吸杂志,2013,36(4):1-9.
12、 KONDO Y, YOSHIMOTO T, YASUDA K, et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system[J]. Int Immunol, 2008, 20(6): 791-800. KONDO Y, YOSHIMOTO T, YASUDA K, et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system[J]. Int Immunol, 2008, 20(6): 791-800.
13、 LIEW FY, PITMAN NI, MCINNES IB. Disease-associated functions of IL-33: the new kid in the IL-1 family[J]. Nat Rev Immunol, 2010, 10(2): 103-110. LIEW FY, PITMAN NI, MCINNES IB. Disease-associated functions of IL-33: the new kid in the IL-1 family[J]. Nat Rev Immunol, 2010, 10(2): 103-110.
14、 ALDONYTE R, JANSSON L, PIITULAINEN E, et al. Circulating monocytes from healthy individuals and COPD patients[J]. Respir Res, 2003, 4(1): 1-8. ALDONYTE R, JANSSON L, PIITULAINEN E, et al. Circulating monocytes from healthy individuals and COPD patients[J]. Respir Res, 2003, 4(1): 1-8.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录